About
Gene Editing Therapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalChina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
56
By Phase
EARLY_PHASE1: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06745973Lead Sponsor
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
EARLY_PHASE1Not yet recruiting
20 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2026
NCT06661148Lead Sponsor
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
PHASE1Not yet recruiting
36 participants
Started: Dec 1, 2024 · Completed: Jun 30, 2027
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...